Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-82.21	-244.52	1374.21
Graham Fair Price	2.21	11.16	10.92
PEG	441.93	1.68	0.31
Price/Book	6.28	0.94	0.88
Price/Cash Flow	-12.44	17.82	20.35
Prices/Earnings	0.52	10.81	10.75
Price/Sales	5.64	6.59	6.24
Price/FCF	-12.44	17.82	20.35
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	164.40	1.01	0.38
Operating Margin	5540.03	0.22	< 0.005
ROA	4.17	< 0.005	< 0.005
ROE	0.02	0.02	5.73
ROIC	< 0.005	0.02	3972.82
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	0.10	-58.04
Dividends QOQ	< 0.005	0.02	2206.64
EBIT QOQ	-1.03	57.00	5453.09
EPS QOQ	0.35	0.06	-81.45
FCF QOQ	-0.44	0.20	-54.54
Revenue QOQ	0.63	< 0.005	-98.87
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.29	0.30	4.15
Quick Ratio	0.53	0.55	3.97
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	16.09	16.00	-0.60
Cash	19.20	19.43	1.20
Capex	-0.03	-0.02	28.05
Free Cash Flow	0.70	0.84	20.66
Revenue	2.27	2.27	< 0.005
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.23	0.25	6.55
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	243.43	-31.64	-87.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating